Items Tagged ‘Cardio3 BioSciences’

December 9, 2009

Mayo Clinic linked biotech plans estimated $74M IPO

By Kelley Luckstein

A Belgium biotech company that licenses Mayo Clinic research and is partially owned by Mayo – Cardio3 BioSciences Cardio3 BioSciences is licensing Mayo Clinic research about “differentiating” stem cells, or turning generic stem cells from bone marrow into cardiac cells.    Post-Bulletin, by Jeff Kiger, 12/8/09

View full entry

Tags: biotech, Cardio3 BioSciences

Contact Us · Privacy Policy